Announce Date | 05/01/2025 |
EPS Normalized Actual | $2.69 (Miss by $-0.14) |
EPS GAAP Actual | $2.69 (Miss by $-0.14) |
Revenue Actual | $2.9162B |
Revenue Surprise | Beat by $2916.2M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2029 | 21.8237 | 13.08 | 20.36219 | 23.42553 | 1 |
Sep 2028 | 20 | 14.27 | 19.13518 | 21.00416 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -7.77 | -7.77 | 2.9162B | -0.48% | 2916.2M |
FQ4 2024 (Dec 2024) | 2.77 | 2.77 | 2.9315B | -72.79% | 2931.5M |
FQ3 2024 (Sep 2024) | 8.76 | 8.76 | 5.3077B | -1.93% | 5307.7M |
FQ2 2024 (Jun 2024) | 3.13 | 3.13 | 5.0112B | -2.02% | 5011.2M |
FQ1 2024 (Mar 2024) | 2.57 | 2.57 | 2.9302B | -87.34% | 2930.2M |
FQ4 2023 (Dec 2023) | 2.74 | 2.74 | 5.0654B | 37.33% | 5065.4M |
FQ3 2023 (Sep 2023) | 3.11 | 3.11 | 5.4104B | 34.02% | 5410.4M |
FQ2 2023 (Jun 2023) | 2.68 | 2.68 | 5.1126B | 37.62% | 5112.6M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 3.8497 | -- | 3.69197 | 3.98813 | 1 |
FQ2 2029 (Jun 2029) | 5.4621 | -- | 5.25212 | 5.5806 | 4 |
FQ1 2029 (Mar 2029) | 5.4431 | -- | 5.23385 | 5.56118 | 3 |
FQ4 2028 (Oct 2028) | 5.2581 | -- | 5.2581 | 5.2581 | 6 |
FQ3 2028 (Jul 2028) | 5.236 | -- | 5.236 | 5.236 | 6 |
FQ2 2028 (Jun 2028) | 5.236 | -- | 5.236 | 5.236 | 6 |
FQ1 2028 (Mar 2028) | 5.218 | -- | 5.218 | 5.218 | 6 |
FQ4 2027 (Oct 2027) | 4.7136 | -- | 4.7136 | 4.7136 | 5 |
FQ3 2027 (Jul 2027) | 4.5013 | -- | 4.5013 | 4.5013 | 5 |
FQ2 2027 (Jun 2027) | 4.5013 | -- | 4.5013 | 4.5013 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 4.94B | -- | 4.79B | 5.08B | 3 |
FQ2 2029 (Jun 2029) | 4.74B | -- | 4.6B | 4.82B | 3 |
FQ1 2029 (Mar 2029) | 4.64B | -- | 4.5B | 4.72B | 3 |
FQ4 2028 (Oct 2028) | 4.41B | -- | 4.41B | 4.41B | 4 |
FQ3 2028 (Jul 2028) | 4.31B | -- | 4.31B | 4.31B | 4 |
FQ2 2028 (Jun 2028) | 7.21B | -- | 7.21B | 7.21B | 8 |
FQ1 2028 (Mar 2028) | 7.05B | -- | 7.05B | 7.05B | 8 |
FQ4 2027 (Oct 2027) | 4.03B | -- | 4.03B | 4.03B | 5 |
FQ3 2027 (Jul 2027) | 3.94B | -- | 3.94B | 3.94B | 5 |
FQ2 2027 (Jun 2027) | 6.58B | -- | 6.58B | 6.58B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -7.77 | -7.77 | 100% | |
FQ4 2024 (Dec 2024) | 2.77 | 2.77 | 100% | |
FQ3 2024 (Sep 2024) | 8.76 | 8.76 | 100% | |
FQ2 2024 (Jun 2024) | 3.13 | 3.13 | 100% | |
FQ1 2024 (Mar 2024) | 2.57 | 2.57 | 100% | |
FQ4 2023 (Dec 2023) | 2.74 | 2.74 | 100% | |
FQ3 2023 (Sep 2023) | 3.11 | 3.11 | 100% | |
FQ2 2023 (Jun 2023) | 2.68 | 2.68 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.92B | $2916.2M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.93B | $2931.5M | 100% |
FQ3 2024 (Sep 2024) | $0B | $5.31B | $5307.7M | 100% |
FQ2 2024 (Jun 2024) | $0B | $5.01B | $5011.2M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.93B | $2930.2M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.07B | $5065.4M | 100% |
FQ3 2023 (Sep 2023) | $0B | $5.41B | $5410.4M | 100% |
FQ2 2023 (Jun 2023) | $0B | $5.11B | $5112.6M | 100% |